Loading...
Global Medical REIT Inc.
GMRE-PA•NYSE
Real Estate
REIT - Healthcare Facilities
$25.01
$-0.29(-1.15%)
Global Medical REIT Inc. (GMRE-PA) Financial Performance & Income Statement Overview
Review Global Medical REIT Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-1.79%
↓ 1.79%
Operating Income Growth
-13.86%
↓ 13.86%
Net Income Growth
-67.82%
↓ 67.82%
Operating Cash Flow Growth
2.35%
↑ 2.35%
Operating Margin
23.98%
↑ 23.98%
Gross Margin
78.63%
↑ 78.63%
Net Profit Margin
5.76%
↑ 5.76%
ROE
1.48%
↑ 1.48%
ROIC
2.61%
↑ 2.61%
Global Medical REIT Inc. (GMRE-PA) Income Statement & Financial Overview
Review Global Medical REIT Inc.'s (GMRE-PA) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $34.95M | $34.17M | $38.67M | $35.07M |
| Cost of Revenue | $7.20M | $3.39M | $21.23M | $7.38M |
| Gross Profit | $27.76M | $30.78M | $17.45M | $27.68M |
| Gross Profit Ratio | $0.79 | $0.90 | $0.45 | $0.79 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $7.71M | $4.38M | $4.59M | $4.45M |
| Operating Expenses | $21.35M | $4.38M | $18.58M | $18.53M |
| Total Costs & Expenses | $28.54M | $7.77M | $25.82M | $25.91M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $7.57M | $7.24M | $6.99M | $6.89M |
| Depreciation & Amortization | $13.89M | $13.82M | $13.99M | $14.08M |
| EBITDA | $24.40M | $24.45M | $26.85M | $22.24M |
| EBITDA Ratio | $0.70 | $0.72 | $0.69 | $0.63 |
| Operating Income | $6.41M | $26.49M | $12.86M | $794000.00 |
| Operating Income Ratio | $0.18 | $0.78 | $0.33 | $0.02 |
| Other Income/Expenses (Net) | -$3.47M | -$24.70M | -$14.81M | -$6.84M |
| Income Before Tax | $2.94M | $1.79M | -$1.95M | $2.31M |
| Income Before Tax Ratio | $0.08 | $0.05 | -$0.05 | $0.07 |
| Income Tax Expense | $0.00 | $0.00 | -$260000.00 | $7.004M |
| Net Income | $2.83M | $3.25M | -$1.69M | $2.25M |
| Net Income Ratio | $0.08 | $0.09 | -$0.04 | $0.06 |
| EPS | $0.02 | $0.03 | -$0.03 | $0.03 |
| Diluted EPS | $0.02 | $0.03 | -$0.03 | $0.03 |
| Weighted Avg Shares Outstanding | $66.84M | $65.74M | $65.59M | $65.57M |
| Weighted Avg Shares Outstanding (Diluted) | $66.84M | $65.74M | $65.59M | $65.57M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan